• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21

    2/11/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email

    As the preterm birth rate remains at an all-time high, continuing education for providers of neonatal intensive care is critical

    Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is pleased to announce NEO: The Conference for Neonatology, a premier educational event dedicated to advancing the field of neonatology. The conference will be held Feb. 19-21 in Las Vegas, Nevada, and will bring together neonatologists, pediatricians, advanced practitioners and allied health professionals from around the globe.

    As a trusted provider of neonatology services for more than 45 years, Pediatrix cares for nearly a quarter of the infants born in the United States that require intensive care.

    The March of Dimes' 2024 Report Card, released in November, reported that the nation's preterm birth rate remains historically high at 10.4%, with 370,000 babies born prematurely in 2023. In 2022, the rate was 10.5%. The U.S. earned a D+ for the third consecutive year, remaining the worst grade in the report's history.

    "These findings emphasize the need for continuous innovation in the field of neonatal-perinatal medicine," said Timothy Biela, M.D., neonatologist at Pediatrix Neonatology of San Antonio and director of the NEO conference. "We are proud to lead research efforts and provide continuing education opportunities not only for our affiliated clinicians, but for all providers of this highly specialized care. Our hope is to improve outcomes for our youngest and most vulnerable patients."

    About the Conference

    Now in its 46th year, the NEO conference addresses the latest advancements, research and best practices in neonatology. The meeting aims to provide a platform for knowledge exchange, professional development and collaboration among health care professionals dedicated to the care of newborns.

    The comprehensive program includes:

    • Plenary sessions on cutting-edge research and clinical practices
    • Interactive workshops and hands-on training sessions
    • Panel discussions with industry experts and thought leaders
    • Networking opportunities with peers and leaders in neonatology
    • Exhibits showcasing the latest technologies and products in neonatal care

    Keynote Speakers

    The NEO conference will feature an impressive lineup of keynote speakers, including renowned experts in the field of neonatology. Among the distinguished speakers are:

    • Dan Ellsbury, M.D., Director of Quality and Safety for Neonatology, the Pediatrix Center for Research, Education, Quality and Safety (CREQS)
    • Elizabeth Foglia, M.D., MSCE, Associate Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine | Children's Hospital of Philadelphia
    • Haresh Kirpalani, M.D., Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine
    • Josef Neu, M.D., Professor of Pediatrics, University of Florida College of Medicine
    • Noelle Younge, M.D., MHS, Jean and George W. Brumley, Jr., M.D., Assistant Professor of Pediatrics, Duke University School of Medicine
    • Robert Ursprung, M.D., MMSc, Director of Quality and Safety for Neonatology, the Pediatrix CREQS

    These thought leaders will share their insights on groundbreaking research, innovative treatments and emerging trends in neonatal care.

    Legends of Neonatology

    Established in 2007, the Legends of Neonatology award honors remarkable individuals whose clinical contributions have helped forge new ground in neonatal medicine. This year's recipient is David K. Stevenson, M.D., Harold K. Faber Professor of Pediatrics, Senior Associate Dean for Maternal and Child Health at the Stanford University School of Medicine and Principal Investigator of the Prematurity Research Center. Over the span of four decades, Dr. Stevenson has been at the forefront of research, professional education and clinical care in neonatology. He has made pioneering contributions to neonatology and pediatrics through extensive research in bilirubin biochemistry, heme oxygenase biology and neonatal jaundice. His work has led to new technologies and standards of care for the treatment of neonatal jaundice.

    Accredited Continuing Education

    Participants attending the NEO conference will have the opportunity to earn accredited continuing education credits. The Pediatrix CREQS is accredited by:

    • The Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians, designating this live activity for a maximum of 20.25 AMA PRA Category 1 Credits™.
    • The American Nurses Credentialing Center's Commission on Accreditation as a provider of nursing continuing professional development, designating this live activity for a maximum of 20.25 nursing contact hour(s).

    About Pediatrix Medical Group

    Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology. The group's high-quality, evidence-based care is bolstered by significant investments in research, education, quality improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,400 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250211765616/en/

    For media inquiries, please contact:

    Jennifer Gutierrez, Corporate Communications

    [email protected]

    954.384.0175 ext. 5684

    Get the next $MD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    SEC Filings

    View All

    Pediatrix Medical Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    8/18/25 4:45:29 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Pediatrix Medical Group Inc.

    10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    8/5/25 7:00:49 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    8/5/25 6:50:27 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Leadership Updates

    Live Leadership Updates

    View All

    Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its board of directors has appointed Kurt D. Newman, M.D., former President and Chief Executive Officer of Children's National Hospital in Washington, D.C. and Professor Emeritus of Surgery and Pediatrics at George Washington University School of Medicine and Health Sciences, as an independent director, effective July 1, 2025. Dr. Newman, a surgeon and nationally recognized leader in pediatric healthcare and a long-term healthcare executive, served as President and Chief Executive Officer of Children's National Hospital for 12 years, after spending over 25 years there as a pediatric sur

    7/1/25 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

    Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

    1/13/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Board Appoints Sylvia Young as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

    5/4/23 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Pediatrix Medical Group

    Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

    12/16/24 7:46:05 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Jefferies with a new price target

    Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

    9/26/24 7:37:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

    6/7/24 8:14:20 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pediatrix Medical Group Announces $250 Million Share Repurchase Program

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its Board of Directors has authorized a share repurchase program of up to $250 million of the Company's outstanding common stock. "In view of our strong cash flow, current and forecasted cash balances and relatively low debt levels, our Board has authorized a $250 million share repurchase program, which we plan to use opportunistically," said Mark S. Ordan, Chair of the Board and Chief Executive Officer. "We will weigh the use of the repurchase program continually against other potential strategic uses of cash to provide the best long-term return to our shareholders and the strongest fu

    8/18/25 4:30:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports Second Quarter Results

    Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.46 per share for the three months ended June 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.53. For the 2025 second quarter, Pediatrix reported the following results: Net revenue of $469 million; Net income of $39 million; and Adjusted EBITDA of $73 million. "Our second quarter operating results exceeded our forecast and reflect continuing strong neonatology patient volumes, stable payor mix, and careful operations management," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical

    8/5/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, August 5, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2025. A detailed press release will be issued the morning of August 5, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and childre

    7/21/25 7:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Invest & Strategy Neeb Don Gregory was granted 81,346 shares (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    8/5/25 5:05:04 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form 3 filed by new insider Neeb Don Gregory

    3 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    8/5/25 5:00:07 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Director Newman Kurt Douglas was granted 9,737 shares (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    8/5/25 5:00:04 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Financials

    Live finance-specific insights

    View All

    Pediatrix Medical Group Reports Second Quarter Results

    Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.46 per share for the three months ended June 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.53. For the 2025 second quarter, Pediatrix reported the following results: Net revenue of $469 million; Net income of $39 million; and Adjusted EBITDA of $73 million. "Our second quarter operating results exceeded our forecast and reflect continuing strong neonatology patient volumes, stable payor mix, and careful operations management," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical

    8/5/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, August 5, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2025. A detailed press release will be issued the morning of August 5, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and childre

    7/21/25 7:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports First Quarter Results

    Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.24 per share for the three months ended March 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.33. For the 2025 first quarter, Pediatrix reported the following results: Net revenue of $458 million; Net income of $21 million; and Adjusted EBITDA of $49 million. "Our strong first quarter results reflect same-unit top-line outperformance versus our expectations, continued steady cost management and the successful results of the portfolio restructuring we completed last year. As a result of our strong f

    5/6/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pediatrix Medical Group Inc.

    SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    11/13/24 4:30:24 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    10/31/24 11:54:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    6/10/24 12:43:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care